Active	Status	Sponsor type	Region	Phase	Filter
17 Active 4 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhu, Yan
NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes	Active, not recruiting	3	408	RoW	HTD1801, berberine ursodeoxycholate, Placebo	HighTide Biopharma Pty Ltd	T2DM (Type 2 Diabetes Mellitus)	03/25	09/25
SURPASS-CN-INS, NCT05691712: A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes	Completed	3	257	RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases	07/24	07/24
TRIUMPH-4, NCT05931367: A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee	Active, not recruiting	3	405	Europe, Canada, US, RoW	Retatrutide, LY3437943, Placebo	Eli Lilly and Company	Obesity, Overweight, Osteo Arthritis Knee	02/26	03/26
TRIUMPH-2, NCT05929079: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight	Active, not recruiting	3	1000	Europe, US, RoW	Retatrutide, LY3437943, Placebo	Eli Lilly and Company	Type 2 Diabetes, Obesity, Overweight, Obstructive Sleep Apnea	05/26	05/26
Qian, Jun
NCT05860465: Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer	Recruiting	2/3	254	RoW	SPH4336 Tablets, SPH4336 Tablets Placebo	Shanghai Pharmaceuticals Holding Co., Ltd	Locally Advanced or Metastatic Breast Cancer	03/25	08/25
NCT04614740: The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors	Recruiting	2	115	RoW	VC004	Jiangsu vcare pharmaceutical technology co., LTD	Locally Advanced Solid Tumor, Metastatic Solid Tumor	01/24	06/24
NCT04689100: Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor	Recruiting	1	259	RoW	JMT101, FOLFIRI(Irinotecan, Leucovorin Calcium, and Fluorouracil); mFOLFOX6((Oxaliplatin, Leucovorin Calcium, and Fluorouracil);, FOLFIRI; mFOLFOX6; Irinotecan;	Shanghai JMT-Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	Advanced Solid Tumor	12/21	06/22
Wu, Chenguang
No trials found
Liu, Haitong
No trials found
Shan, Xiuhong
No trials found
Xie, Yong
No trials found